Power morcellator for uterine fibroid removal not linked to cancer risk
the ONA take:
According to new findings published in the journal JAMA Oncology, researchers have found that the risk of bits of hidden cancerous tumors spreading throughout the abdomen when a power morcellator is used to remove fibroids in the uterus is low.
Before the U.S. Food and Drug Administration issued a black-box warning on the devices last November that the morcellator could spread and worsen an undetected cancerous uterine tumor, power morcellators were commonly used during minimally invasive surgery to remove uterine fibroids.
Uterine fibroids, which are non-cancerous growths in the uterine wall, are very common, but sometimes need to be removed when they cause pelvic pain and heavy menstrual bleeding. Treatment options include a hysterectomy to remove the uterus or surgery to remove the fibroids.
For the study, researchers identified 42,000 American women who had fibroids removed between 2006 and 2012, 3,200 of which were removed with power morcellators.
Of those, three were found to have uterine cancer, meaning the odds of developing uterine cancer after uterine fibroid removal was about 1 in 1,000 patients compared with 1 in 528 among women whose fibroid removal did not involve the power morcellators. The researchers note that the findings are reassuring.
Risk of bits of hidden cancerous tumors spreading throughout the abdomen when a power morecellator is used to remove fibroids in the uterus is low.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- Screening Recommendations for Children with Common Cancer Predisposition Syndromes
- Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Lack of Transfusion Services a Barrier to Hospice Care for Patients With Blood Cancers
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
- Study Questions Safety of E-cigarettes vs Regular Tobacco Cigarettes
- Changes in Pulmonary Function Tests in Breast Carcinoma Patients Treated With Locoregional Post-mastectomy Radiotherapy: Results of a Pilot Study
- Increases in Liver Cancer Incidence Influenced by Higher Rates of Comorbidities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|